ERUSALEM - After 61 years of pumping blood, Marie Carty's heart was failing her. Months earlier she had given up her two-mile walk on the boardwalk of her New Jersey hometown along the Atlantic Ocean. She could barely make it from the parking lot to the view of the water. Although Carty knew she needed a new heart, she was afraid hers wouldn't last during the long wait for a transplant. Desperate for an alternative, Carty found the Israeli-Thai company Theravitae, which has begun performing an experimental procedure that multiplies stem cells taken from a patient's own blood and injects...